Patent · US Active

Antibacterial peptide with activity against B. anthracis

US8227423B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2005
Grant dateJul 24, 2012
Priority date—
Expiry dateJan 13, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/04
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed is a therapeutic peptide useful in the treatment or prevention of infection caused by Gram-positive bacteria such as Bacillus anthracis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.